Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,502Revenue $M395Net Margin (%)16.3Altman Z-Score5.7
Enterprise Value $M1,499EPS $2.0Operating Margin %19.4Piotroski F-Score8
P/E(ttm)24.0Beneish M-Score-3.1Pre-tax Margin (%)18.9Higher ROA y-yY
Price/Book5.510-y EBITDA Growth Rate %4.4Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %11.0Current Ratio2.3Lower Leverage y-yY
Price/Free Cash Flow28.8y-y EBITDA Growth Rate %39.8ROA % (ttm)13.4Higher Current Ratio y-yY
Dividend Yield %--PEG2.0ROE % (ttm)26.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M31.3ROIC % (ttm)25.1Gross Margin Increase y-yY

Gurus Latest Trades with CBM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
CBMJoel Greenblatt 2015-06-30 Add0.08%$35.71 - $46.24
$ 47.8616%Add 341.54%268,701
CBMJoel Greenblatt 2015-03-31 Reduce$21.34 - $39.63
$ 47.8662%Reduce 22.55%60,855
CBMJoel Greenblatt 2014-12-31 Buy 0.01%$16.33 - $24.12
$ 47.86125%New holding78,575
CBMJoel Greenblatt 2013-03-31 Sold Out -0.09%$11.27 - $12.79
$ 47.86301%Sold Out0
CBMJoel Greenblatt 2012-12-31 Buy 0.09%$9.34 - $13.96
$ 47.86321%New holding142,352
CBMJoel Greenblatt 2012-09-30 Sold Out -0.02%$9.01 - $13.01
$ 47.86333%Sold Out0
CBMJoel Greenblatt 2012-06-30 Buy 0.02%$5.96 - $9.16
$ 47.86577%New holding30,208
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CBM is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

CBM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KORB WILLIAM BDirector 2015-08-27Sell3,600$48-0.29view
KORB WILLIAM BDirector 2015-08-10Sell1,000$51-6.16view
HENDRIX LEON J JRDirector 2015-08-05Sell4,956$53.8-11.04view
KLOSK STEVEN MPresident & CEO 2015-08-04Sell100,000$50.04-4.36view
SARGEN GREGORYExecutive Vice President & CFO 2015-08-03Sell41,250$49.6-3.51view
KAUFTHAL ILANDirector 2015-05-21Sell50,000$41.3115.86view
SARGEN GREGORYEVP & CFO 2015-05-11Sell25,000$38.4424.51view
SARGEN GREGORYEVP & CFO 2015-02-12Sell25,000$32.6446.63view
Magnini AldoManagin Director-Profarmaco 2015-02-12Sell7,500$32.7546.14view
KLOSK STEVEN MPresident & CEO 2015-02-10Sell45,000$30.3257.85view

Quarterly/Annual Reports about CBM:

News about CBM:

Articles On GuruFocus.com
Cambrex Corp. Reports Operating Results (10-Q) Aug 04 2010 
Cambrex Corp. Reports Operating Results (10-Q) May 05 2010 
Does Cambrex Corporation Have Earnings Persistence? Apr 28 2010 
Cambrex Corp. Reports Operating Results (10-Q) Nov 04 2009 

More From Other Websites
CAMBREX CORP Files SEC form 8-K, Change in Directors or Principal Officers Aug 21 2015
Abiomed, Cambrex Show Why Bigger Isn't Always Better Aug 13 2015
CAMBREX CORP Financials Aug 06 2015
10-Q for Cambrex Corp. Aug 01 2015
Edited Transcript of CBM earnings conference call or presentation 30-Jul-15 12:00pm GMT Jul 31 2015
Cambrex Corp Earnings Call scheduled for 8:00 am ET today Jul 30 2015
Cambrex posts 2Q profit Jul 30 2015
Cambrex posts 2Q profit Jul 30 2015
CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 30 2015
Q2 2015 Cambrex Corp Earnings Release - Before Market Open Jul 30 2015
Cambrex Reports Second Quarter 2015 Financial Results Jul 30 2015
Cambrex to Announce Second Quarter 2015 Financial Results on July 30, 2015 Jul 28 2015
12 market-beating stocks from a 214-year-old strategy Jul 10 2015
Forget Biogen (BIIB), Buy These 3 Biotechnology Stocks Instead - Stocks in the News Jul 06 2015
The Zacks Analyst Blog Highlights: NeoPhotonics, Isle of Capri Casinos, Cambrex, Ambarella and... Jul 06 2015
7 Hot Growth Stocks that Have Outrun the Market in 1H15 - Analyst Blog Jul 02 2015
Can Cambrex Keep Profits Healthy On Gilead Pact? Jun 26 2015
Exact Sciences Corporation (EXAS) Falls: Stock Goes Down 5.5% - Tale of the Tape Jun 26 2015
Alder Biopharmaceuticals (ALDR) in Focus: Stock Falls 8.3% - Tale of the Tape Jun 26 2015
Will Cambrex (CBM) Continue to Surge Higher? - Tale of the Tape Jun 16 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)